Letko, Brosseau & Associates Inc Oncorus, Inc. Transaction History

Letko, Brosseau & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$1.44 - $5.62 $49,536 - $193,328	34,400 Added 138.99%	59,150 $105,000
Q2 2021 Jul 29, 2021	BUY	$13.3 - $17.3 $66,500 - $86,500	5,000 Added 25.32%	24,750 $342,000
Q1 2021 May 11, 2021	BUY	$11.89 - $35.55 $104,037 - $311,062	8,750 Added 79.55%	19,750 $275,000
Q4 2020 Feb 05, 2021	BUY	$15.0 - $35.15 $165,000 - $386,650	11,000 New	11,000 $356,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.